MNOV MEDICINOVA INC

$1.32 -0.38%

Healthcare · Pharmaceutical Preparations

MEDICINOVA INC (MNOV) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $65 million. Shares last traded at $1.32, 49.0% below their 52-week high. Over the past year the stock is down 5.7%. MNOV trades at a price-to-earnings ratio of 5.42, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 2928.8%, above the peer median of -0.1%. Revenue declined 59.0% year over year.

Market Cap

$65M

Shares Out

49.2M

EPS (TTM)

$-0.43

P/E Ratio

5.42

P/S Ratio

158.60

P/B Ratio

1.65

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.59

52-Week Low

$1.20

Volume

414

Avg Vol (3m)

693.333

Performance

+2.72%

-4.35%

-7.37%

-13.16%

YTD

+0.00%

-5.71%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.96

SMA (50)

$1.38

SMA (200)

$1.42

Price vs SMA50

-4.54%

Price vs SMA200

-6.83%

ATR (14)

$0.04

Financials

Revenue

$0M

Net Income

$12M

Gross Margin

—

Operating Margin

-3242.5%

Net Margin

2928.8%

Return on Equity

30.4%

Return on Assets

28.1%

Current Ratio

9.09

Debt / Equity

0.00

Revenue Growth (YoY)

-59.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.05	2026-05-14
FY 2025	$-0.24	2026-03-10
Q3 2025	$-0.19	2025-11-12
Q2 2025	$-0.13	2025-08-14
Q1 2026	$-0.06	2026-05-14
FY 2025	$-0.23	2026-03-10

Full earnings history →

Pharmaceutical Preparations peers

MNOV vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

5.42 / 16.82 med

-68% discount

P/S vs peers

158.60 / 3.54 med

+4383% premium

Net margin vs peers

2928.8% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.